查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946354

肺功能监测设备市场－全球产业规模、份额、趋势、机会及预测（依产品类型、最终用户、地区及竞争格局划分，2021-2031年）

Lung Monitoring Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球肺部监测设备市场预计将从 2025 年的 41.6 亿美元成长到 2031 年的 61.1 亿美元，复合年增长率达到 6.62%。

肺功能监测设备是专门用于诊断和治疗的仪器，旨在评估关键的呼吸参数，例如气体交换、肺容量和气流阻塞情况，从而有效管理肺部疾病。市场成长的主要驱动因素是慢性呼吸系统疾病盛行率的上升以及老年人口的成长，老年人更容易患肺部疾病。例如，国际药学联合会 (FIP) 报告称，到 2024 年，全球将有 3.91 亿人患有慢性阻塞性肺病(COPD)，这使得人们迫切需要准确的评估工具来预防长期併发症，并推动医疗机构对这些设备的广泛应用。

市场概览
预测期 2027-2031
市场规模：2025年 41.6亿美元
市场规模：2031年 61.1亿美元
复合年增长率：2026-2031年 6.62%
成长最快的细分市场 肺计量计
最大的市场 北美洲

然而，由于先进监测系统的高昂实施成本以及不完善的报销体系（尤其是在新兴经济体），该市场面临许多障碍。这些经济障碍阻碍了低收入地区的医疗服务提供者获得最新的呼吸照护技术，从而有效地限制了市场渗透率。儘管临床上对全面呼吸健康管理的需求日益增长，但这些经济限制阻碍了市场扩张，并使最需要这些工具的地区无法获得必要的诊断工具。

市场驱动因素

智慧穿戴式监测设备的科技进步正在革新全球肺部监测设备市场，显着提升诊断准确性和患者便利性。人工智慧和非接触式感测器的应用，无需依赖笨重的硬体即可对呼吸功能进行连续评估，这与行业向无创、便捷解决方案转型的趋势相契合。例如，2025年6月，Mindset Medical宣布其一款纯软体应用程式已获得FDA核准，该程式能够利用标准智慧型手机相机测量呼吸频率。这项进展表明，数位健康工具正在降低进入门槛，并促进呼吸追踪技术在不同患者群体中的普及应用。

同时，随着医疗系统寻求减少住院治疗，远端患者监护和居家医疗的兴起创造了巨大的市场机会。这一趋势的驱动力在于，人们需要在传统临床环境之外进行慢性病管理，而日益恶化的环境因素尤其加剧了这种需求。美国肺臟协会指出，到2025年，美国将有约1.56亿人居住在空气污染水平不健康的地区，这将持续推高对家庭管理解决方案的需求。因此，主要市场参与者正从这些分散式模式中实现强劲成长。瑞思迈（ResMed）公布，截至2025年7月的财年收入达13亿美元，年增10%，凸显了远距呼吸照护技术的商业性可行性及其日益普及。

市场挑战

全球肺部监测设备市场的扩张受到高昂的实施成本和先进监测系统报销体係不足的显着限制。医疗机构，尤其是在新兴经济体，往往面临严重的资金限制，难以投资购买现代化的诊断设备。当保险公司和公共医疗计画未能充分涵盖这些技术时，这种障碍会进一步加剧，使得许多医疗机构难以负担先进的呼吸系统治疗。因此，医院被迫推迟必要的设备升级，这直接阻碍了精准监测工具的普及，并限制了呼吸系统疾病负担尤其沉重的地区的市场渗透率。

经济上的不便不仅降低了潜在的市场收入，也导致患者照护效率低下，造成巨大的经济损失。无法采用这些设备会导致诊断延误和疾病管理不善。据欧洲呼吸学会称，到2025年，慢性呼吸系统疾病的漏诊和误诊将导致欧洲地区每年损失约210亿美元。这一数字凸显了资金短缺和财务限制如何阻碍监测解决方案的广泛应用，使市场无法充分发挥其潜力，同时加重医疗保健系统的长期经济负担。

市场趋势

多功能心肺监测设备的研发正在改变市场格局，它将多种诊断功能整合到紧凑的临床级工具中，用于进行全面的健康评估。鑑于心肺功能在慢性病管理中的重要性，製造商正在加速研发能够同时追踪心血管和肺功能指标的设备。这种整合化设计无需使用多个独立设备，提高了患者的便利性，并增强了远端临床评估的数据品质。例如，Withings公司于2025年11月获得了FDA对其BeamO的批准。 BeamO是一款四合一多功能设备，将数位听诊器、心电图仪和血氧仪整合于一个携带式单元中，零售价为249.95美元（约32,000日圆）。

同时，随着业界重心从被动给药转向提高用药依从性和数据驱动的治疗管理，智慧互联吸入器和雾化器的应用正加速发展。这些新一代系统与数位健康生态系统连接，弥合了患者与医疗服务提供者之间的鸿沟，确保呼吸系统治疗得到正确实施并进行即时监测。这种互联性支持主动介入策略，有助于预防疾病进展并减轻急诊医疗机构的负担。Omron Healthcare于2025年10月宣布，其雾化器累计销量已突破5000万台，这正反映了这一趋势，也展现了呼吸管理解决方案在互联医疗网络中的全球规模和不断扩大的覆盖范围。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球肺功能监测设备市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品类型（肺计量计、脉动式血氧监测仪系统、二氧化碳测量仪、其他）
    • 按最终使用者（医院/诊所、门诊护理中心、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

6. 北美肺功能监测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲肺功能监测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区肺功能监测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲肺功能监测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章 南美洲肺功能监测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球肺功能监测设备市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Baxter International Inc.
  • Becton, Dickinson and Company
  • ICU Medical Inc.
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medtronic plc
  • Nihon Kohden Corporation
  • ResMed Inc.
  • Teleflex Incorporated.
  • Vyaire Medical, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 19509

The Global Lung Monitoring Devices Market is projected to expand from USD 4.16 Billion in 2025 to USD 6.11 Billion by 2031, achieving a compound annual growth rate of 6.62%. Lung monitoring devices are specialized diagnostic and therapeutic tools designed to evaluate critical respiratory parameters, such as gas exchange, lung capacity, and airflow obstruction, ensuring effective management of pulmonary conditions. The market's growth is primarily driven by the increasing prevalence of chronic respiratory disorders and a growing geriatric population that is highly susceptible to lung ailments. For instance, the International Pharmaceutical Federation reported in 2024 that 391 million individuals globally were living with chronic obstructive pulmonary disease, creating an urgent need for accurate assessment tools to prevent long-term complications and driving their adoption across healthcare facilities.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.16 Billion
Market Size 2031USD 6.11 Billion
CAGR 2026-20316.62%
Fastest Growing SegmentSpirometers
Largest MarketNorth America

However, the market faces a significant obstacle in the form of high acquisition costs for advanced monitoring systems, particularly when combined with insufficient reimbursement frameworks in emerging economies. These financial barriers restrict access to modern respiratory care technologies for healthcare providers in low-income regions, effectively limiting market penetration. Despite the growing clinical necessity for comprehensive respiratory health management, these economic constraints prevent the broader expansion of the market and hinder the availability of essential diagnostic tools in areas where they are often needed most.

Market Driver

Technological advancements in smart and wearable monitoring devices are revolutionizing the Global Lung Monitoring Devices Market by significantly improving diagnostic precision and patient convenience. The incorporation of artificial intelligence and contactless sensors enables the continuous evaluation of respiratory functions without relying on cumbersome hardware, aligning with the industry's shift toward non-invasive, accessible solutions. For example, Mindset Medical announced in June 2025 that it received FDA clearance for a software-only application capable of measuring respiratory rates using standard smartphone cameras. This development illustrates how digital health tools are lowering barriers to entry and fostering the widespread adoption of respiratory tracking technologies across a diverse range of patient demographics.

Simultaneously, the transition toward remote patient monitoring and home healthcare is creating substantial market opportunities as healthcare systems aim to decrease hospital admissions. This trend is fueled by the necessity to manage chronic conditions outside traditional clinical settings, a need intensified by worsening environmental factors. The American Lung Association noted in 2025 that approximately 156 million people in the U.S. lived in areas with unhealthy air pollution levels, sustaining the demand for home-based management solutions. Consequently, major market players are experiencing robust growth from these decentralized models; ResMed reported a 10% revenue increase to $1.3 billion in its July 2025 quarterly results, highlighting the commercial viability and rising uptake of remote respiratory care technologies.

Market Challenge

The expansion of the Global Lung Monitoring Devices Market is heavily restricted by the high acquisition costs of advanced monitoring systems and inadequate reimbursement structures. Healthcare facilities, particularly those in emerging economies, often face significant capital constraints that prevent investment in modern diagnostic equipment. This barrier is exacerbated when insurers and public health programs provide insufficient coverage for these technologies, making advanced respiratory care financially unfeasible for many providers. As a result, hospitals are frequently forced to delay necessary equipment upgrades, which directly stifles the adoption of precise monitoring tools and limits market penetration in regions where the burden of respiratory disease is often highest.

This lack of financial accessibility not only reduces potential market revenue but also creates inefficiencies in patient care that lead to substantial economic losses. The inability to deploy these devices contributes to missed diagnoses and poor disease management. According to the European Respiratory Society, in 2025, the underdiagnosis and misdiagnosis of chronic respiratory diseases cost the European region an estimated $21 billion annually. This figure underscores how funding gaps and financial constraints impede the widespread integration of monitoring solutions, preventing the market from reaching its full potential while increasing the long-term economic strain on healthcare systems.

Market Trends

The development of multi-parameter cardio-respiratory devices is transforming the market by consolidating various diagnostic functions into compact, clinical-grade tools for holistic health assessment. Manufacturers are increasingly designing devices that simultaneously track cardiovascular and pulmonary metrics, acknowledging the critical relationship between heart and lung function in the management of chronic diseases. This convergence simplifies the patient experience by eliminating the need for multiple disparate gadgets and enhances the quality of data available for remote clinical evaluation. For instance, Withings received FDA clearance in November 2025 for its BeamO device, a 4-in-1 multiscope retailing for $249.95 that combines a digital stethoscope, electrocardiogram, and oximeter into a single handheld unit.

In parallel, the adoption of smart connected inhalers and nebulizers is gaining momentum as the industry shifts priority toward medication adherence and data-driven therapeutic management rather than passive drug delivery. These next-generation systems integrate with digital health ecosystems to bridge the gap between patients and providers, ensuring respiratory treatments are administered correctly and monitored in real-time. This connectivity supports proactive intervention strategies that can prevent disease progression and reduce the burden on acute care facilities. Highlighting this trend, Omron Healthcare announced in October 2025 that cumulative sales of its nebulizers had surpassed 50 million units, demonstrating the massive global scale and growing reach of these respiratory management solutions within connected care networks.

Key Market Players

  • Baxter International Inc.
  • Becton, Dickinson and Company
  • ICU Medical Inc.
  • Koninklijke Philips N.V.
  • Masimo Corporation
  • Medtronic plc
  • Nihon Kohden Corporation
  • ResMed Inc.
  • Teleflex Incorporated.
  • Vyaire Medical, Inc.

Report Scope

In this report, the Global Lung Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lung Monitoring Devices Market, By Product Type

  • Spirometers
  • Pulse Oximeters
  • Capnographs
  • Others

Lung Monitoring Devices Market, By End User

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Lung Monitoring Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lung Monitoring Devices Market.

Available Customizations:

Global Lung Monitoring Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Lung Monitoring Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Spirometers, Pulse Oximeters, Capnographs, Others)
    • 5.2.2. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Lung Monitoring Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Lung Monitoring Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Lung Monitoring Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Lung Monitoring Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End User

7. Europe Lung Monitoring Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Lung Monitoring Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End User
    • 7.3.2. France Lung Monitoring Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Lung Monitoring Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Lung Monitoring Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Lung Monitoring Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End User

8. Asia Pacific Lung Monitoring Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Lung Monitoring Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Lung Monitoring Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Lung Monitoring Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Lung Monitoring Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Lung Monitoring Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End User

9. Middle East & Africa Lung Monitoring Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Lung Monitoring Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Lung Monitoring Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Lung Monitoring Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End User

10. South America Lung Monitoring Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Lung Monitoring Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Lung Monitoring Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Lung Monitoring Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Lung Monitoring Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Baxter International Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Becton, Dickinson and Company
  • 15.3. ICU Medical Inc.
  • 15.4. Koninklijke Philips N.V.
  • 15.5. Masimo Corporation
  • 15.6. Medtronic plc
  • 15.7. Nihon Kohden Corporation
  • 15.8. ResMed Inc.
  • 15.9. Teleflex Incorporated.
  • 15.10. Vyaire Medical, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer